Case - Rapid and Persistent Selection of the K103N Mutation as a Majority Quasispecies in a HIV1-Patient Exposed to Efavirenz for Three Weeks: A Case Report and Review of the Literature

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Genetics

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent cases - Genetics

	Identical Twins With Ovarian Hilar Cell Hyperplasia: A Case Report
	A Patient with Typical Clinical Features of Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) but Without an Obvious Genetic Cause: A Case Report
	Familial Esophageal Atresia
	Distal Myopathy in Multi-minicore Disease

Cases archive

Recent news - Genetics

	Gefitinib Superior to Standard Chemotherapy in NSCLC Patients With EGFR Mutations - (DGNews)
	Genomewide Association Study of Leprosy - (N Engl J Med)
	MMP12, Lung Function, and COPD in High-Risk Populations - (N Engl J Med)
	Carrier Screening Associated With Decrease in Incidence of Cystic Fibrosis - (DGNews)
	Use of genetics in the clinical evaluation of cardiomyopathy - (JAMA)

News archive

Recent webcasts/CME - Genetics

Optimizing the Use of Chemotherapy as the Backbone of Breast Cancer Treatment: An Update of the Latest Evidence

	Genetic Prognostic Testing for Adolescent Idiopathic Scoliosis
	Alpha1-Antitrypsin Augmentation: Approaches and Benefits
	A Genome-Wide Association Study Exploring Statin-Induced Myopathy
	Prothrombotic States

Webcasts/CME archive

personal edition > genetics > cases

Cases

E-Mail this case to a colleague

Rapid and Persistent Selection of the K103N Mutation as a Majority Quasispecies in a HIV1-Patient Exposed to Efavirenz for Three Weeks: A Case Report and Review of the Literature

Presented by:	Journal of Medical Case Reports / Ennio Polilli, Giustino Parruti, Luana Cosentino, Federica Sozio, Annalisa Saracino, Augusta Consorte, Gioacchino Angarano, Francesco Di Masi, Elena Mazzotta and Paolo Fazii
Summary points:	A 55-year-old Caucasian male was switched to efavirenz, zidovudine and lamivudine in 2003, while on viral suppression in his first-line highly active anti-retroviral treatment regimen. In 2005, the patient interrupted his medications 3 weeks after simplification. Genotyping resistance testing assay is described. The authors discuss the need to rule out the presence of the K103N mutation after even minimal exposure to efavirenz.
Accreditation:	Not available
Other:

Additional Information

Text:	Yes
Picture/Slides:	No
Discussion Group:	No
Feedback possible:	No
Minimum connection needed:	28.8
Plugins needed:	No
Registration:	No

Go to case

E-Mail this case to a colleague